1. Abnormal expression of ANXA2 predicts cholangiocarcinoma's poor prognosis and exacerbates malignancy via activating β-catenin signaling. (September 2018) Authors: Yang, R.; Wang, D.; Han, S.; Huo, L.; Ding, D.; Peng, R.; Ji, G.; Zhang, Y.; Yu, Y.; Li, X. Journal: HPB Issue: Volume 20(2018)Supplement 2 Page Start: S686 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗